Circulating tumor cells and cell-free tumor DNA analyses in urothelial cancer using the LiquidBiopsy platform
Abstract. Background:. Emerging data suggested that liquid biopsy such as detection of circulating tumor cells (CTCs) and cell-free tumor DNA analysis augments the management of patients with urothelial cancer (UC). We presented our pilot experience of liquid biopsy using the Ion Torrent platform to...
Main Authors: | Minoru Kobayashi, Hideyuki Abe, Kyoko Arai, Satoshi Murakami, Takao Kamai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health
2022-06-01
|
Series: | Current Urology |
Online Access: | http://journals.lww.com/10.1097/CU9.0000000000000091 |
Similar Items
-
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
by: Qianwei Ye, et al.
Published: (2019-07-01) -
Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy
by: Akinori Nukui, et al.
Published: (2017-05-01) -
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01) -
Prospects for Comprehensive Analyses of Circulating Tumor Cells in Tumor Biology
by: Masahiko Aoki, et al.
Published: (2020-05-01) -
Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies
by: Marta Tellez-Gabriel, et al.
Published: (2020-12-01)